NVIDIA CORP
Institutional investor · Portfolio as of Q4 2024
Top Holdings5 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ARM Holdings PLC Sponsored ADR | 1.1M | $135.9M | 44.6% | $75.14 | +67.57% | 5 qtrssince 2023-Q4 | Decreased 0 |
APPLIED DIGITAL CORP | 7.7M | $59M | 19.4% | $8.19 | -2.69% | 2 qtrssince 2024-Q3 | Unchanged 0 |
RECURSION PHARMACEUTICALS IN | 7.7M | $52.1M | 17.1% | $9.86 | -31.34% | 5 qtrssince 2023-Q4 | Unchanged 0 |
NEBIUS GROUP NV | 1.2M | $33M | 10.8% | $26.92 | 0.00% | 1 qtr | New 92 |
WERIDE INC | 1.7M | $24.7M | 8.1% | $13.85 | 0.00% | 1 qtr | New 91 |
NVIDIA CORP manages $304.5M across 5 positions as of Q4 2024. Top holdings: ARM (44.6%), APLD (19.4%), RXRX (17.1%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.
Added 2 new positions, exited 3, trimmed 1. Top move: NBIS (NEW, conviction 92). Portfolio: $305M across 5 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer